Form 4: BioRestorative Therapies Director Dale Broadrick Sells Shares
SEC Form 4
Director Dale Broadrick sold 1,112 shares of BioRestorative Therapies, Inc. on October 28, 2024, at a price of $1.58 per share.
Summary
- On October 28, 2024, Dale Broadrick, a director of BioRestorative Therapies, Inc., sold 1,112 shares of common stock at $1.58 per share.
- Following the transaction, Broadrick directly owns 445,933 shares and indirectly owns 477,972 shares through Fleetco, Inc., where he is a 93% shareholder.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports a transaction. The sale of shares by a director could be interpreted negatively, but without further context, it's difficult to assess the overall impact.
Negatives
- A director selling shares can sometimes be perceived negatively by investors.
Risks
- Director share sales could potentially signal a lack of confidence in the company's future performance, although this is not explicitly stated.
Industry Context
Form 4 filings are a routine part of the US stock market and are required by the SEC to provide transparency on insider transactions.
Stakeholder Impact
- Shareholders may react to the news of a director selling shares.
Key Dates
| Date | Description |
|---|---|
| 10/28/2024 | Date of the transaction (sale of shares). |
| 11/04/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.